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Dietary factors play an important role in kidney stone
formation, and dietary modification can reduce the risk of
stone recurrence. Because stone recurrence rates may be
as high as 30–50% after 5 years, individualized dietary
intervention to prevent stone recurrence should be offered
to every patient willing to participate in a diagnostic work-up
and to adhere to treatment recommendations. The necessity
of prescribing medical therapy to select patients does not
obviate the need for an effective dietary and/or fluid
prescription. In this review, we summarize specific dietary
and fluid recommendations, and emphasize several key
concepts. First, risk factors for stone formation vary by age
and sex. Second, recommendations should be tailored to the
individual patient based on urinary profile and stone type.
Third, it is essential that the patient perform follow-up
measurements to evaluate the impact of dietary
recommendations. Fourth, it is important to distinguish stone
passage from new stone formation. If a patient implements
dietary changes and then passes a pre-existing stone, this
does not mean that the intervention was not effective.
Finally, because of the relative paucity of randomized trials,
observational studies provide the basis for many clinical
recommendations. Adequate fluid intake and appropriate
dietary modifications may substantially reduce the morbidity
and costs associated with recurrent nephrolithiasis.
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Kidney stone disease is common and the prevalence is rising
in the US1 and other countries. Up to 12% of men and 6% of
women in the US will develop a kidney stone at some point
in their lives.1 Lifestyle factors, including diet and obesity, are
likely responsible for this increase.
Because stone recurrence rates may be as high as 30–50%
after 5 years,2 specific, individualized dietary interventions to
prevent stone recurrence should be offered to every patient
willing to participate in a diagnostic work-up and to adhere
to treatment recommendations. The necessity of prescribing
medication to select patients does not obviate the need for an
effective dietary and/or fluid prescription. For example, the
reduction in urinary calcium excretion obtained with a
thiazide diuretic may be inadequate without concurrent
dietary sodium restriction.
Because most data in the field of diet and stone disease are
from observational and physiologic studies rather than
randomized trials, consensus on the specifics of dietary
modification is lacking. The following discussion is based on
several key concepts. First, although short-term intervention
studies examining changes in urine composition are of
interest, clinical recommendations should be based on studies
using actual stone formation as the outcome. Stone formation
cannot be perfectly predicted by urinary composition, and it is
likely that there are many factors that influence urinary
supersaturation but are not accounted for by the formulas
used to calculate supersaturation (e.g., phytate). Second, it is
important to tailor recommendations based on stone type and
urinary profile (two 24-h urine collections obtained at least
6 weeks after a stone episode are required as part of the initial
evaluation). For example, we do not recommend dietary
oxalate restriction to individuals with pure uric acid stones or
to those with low urinary oxalate excretion. Third, dietary risk
factors vary by age and sex. Fourth, it is essential that the
patient perform follow-up measurements to evaluate the
impact of dietary recommendations. If the urine composition
does not change despite a dietary change, then alternative
approaches should be tried. Finally, it is important to
distinguish stone passage from new stone formation. If
a patient implements dietary changes and then passes a
pre-existing stone, this does not indicate treatment failure.
DIETARY RISK FACTORS FOR CALCIUM STONE DISEASE
Because approximately 80% of kidney stones contain
calcium, and the majority of calcium stones consist primarily
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of calcium oxalate,3 most studies to date have focused on the
prevention of calcium oxalate nephrolithiasis. Putative diet-
ary promoters and inhibitors of calcium kidney stones are
listed in Table 1. Specific dietary prescriptions based on
urinary abnormalities are presented in Table 2.
Calcium
Until relatively recently, higher calcium intake was thought to
increase the risk of stone formation. In normal individuals,
approximately 20% of ingested calcium is absorbed; this
proportion increases in individuals with idiopathic hyper-
calciuria.4 However, there is substantial evidence demonstrat-
ing that a higher calcium diet is associated with a reduced
risk of stone formation. One potential mechanism to explain
this apparent paradox is that the higher calcium intake will
bind dietary oxalate in the gut, thereby reducing oxalate
absorption and urinary excretion. It is also possible that dairy
products (the major source of dietary calcium) may contain
other inhibitory factors.
Recent data from several large prospective observational
studies in men and women consistently support a reduced
risk of stone formation with increasing dietary calcium
intake. Compared to individuals in the lowest quintile of
dietary calcium intake, those in the highest quintile had more
than a 30% lower risk of forming a stone.5–7 These results
were adjusted for multiple factors, including age, body mass
index, total fluid intake, the use of thiazide diuretics, and the
intake of nutrients such as animal protein, magnesium,
phosphorous, sodium, and potassium. As an example of how
risk factors vary by age, there was no association between
dietary calcium and stone formation in men aged 60 years or
older.8
A 5-year randomized controlled clinical trial compared
stone recurrence in patients with a history of calcium oxalate
nephrolithiasis and idiopathic hypercalciuria assigned to a
diet low in calcium (400 mg/day) or to a diet with normal
calcium content (1200 mg/day) and low amounts of animal
protein and salt.9 At the end of the study, the risk of
developing a recurrent stone on the normal calcium diet was
51% lower than for the low-calcium diet.9 Because dietary
sodium and animal protein may both contribute to the
formation of calcium stones, this trial, although suggestive,
did not directly address the independent role of dietary
calcium in the pathogenesis of kidney stones.
Data also suggest that the impact of supplemental calcium
is different from dietary calcium. In an observational study of
older women, calcium supplement users were 20% more
likely to form a stone than women who did not take
supplements.6 In younger women and men, there was no
association between calcium supplement use and risk of
stone formation.5,7 The discrepancy between the risks from
dietary calcium and calcium supplements may be due to the
timing of calcium intake. In these studies, calcium supple-
ments were often taken in between meals, which would
diminish binding of dietary oxalate. The Women’s Health
Initiative clinical trial also demonstrated an increased risk of
stones with calcium supplementation, but these results are
difficult to interpret. The Women’s Health Initiative partici-
pants were instructed to take their supplements with meals,
but the supplements contained both calcium and vitamin D.
A patient with calcium urolithiasis who wishes to continue
calcium supplementation should collect 24-h urine samples
on and off the supplement. If the urinary supersaturation of
the calcium salt in question increases during the period of
supplement use, the supplement should be discontinued.
Oxalate
The role of dietary oxalate in the pathogenesis of calcium
oxalate nephrolithiasis is unclear.10 First, the proportion of
urinary oxalate derived from dietary oxalate is controversial;
estimates range from 10 to 50%.10 A large amount of urinary
oxalate is derived from the endogenous metabolism of
glycine, glycolate, hydroxyproline, and dietary vitamin C.
Second, much of the oxalate in food may not be readily
absorbed due to low bioavailability. Finally, significant
Table 1 | Putative dietary promoters and inhibitors of calcium
kidney stonesa
Dietary factor Proposed mechanism(s)
Promoters
Oxalate Increased urinary oxalate excretion
Sodium Increased urinary calcium excretion
Animal protein Increased urinary calcium and uric acid excretion;
reduced urinary citrate excretion
Vitamin C Increased oxalate generation and excretion
Carbohydrates Increased urinary calcium excretion
Inhibitors
Dietary calcium Binding of dietary oxalate in gut
Potassium Increased urinary citrate excretion;
reduced urinary calcium excretion
Phytate Inhibition of calcium oxalate crystal formation
Magnesium Reduced dietary oxalate absorption; inhibition
of calcium oxalate crystal formation
Vitamin B6 Vitamin B6 deficiency may increase oxalate
production and oxaluria
aPhosphorus and n-3 fatty acids are discussed in the text.
Table 2 | Dietary prescription for calcium stone prevention
according to urinary risk factor
Urinary abnormality Dietary changes
High calcium Adequate dietary calcium intake
Reduce non-dairy animal protein intake
(5–7 servings of meat, fish, or poultry/week)
Reduce sodium intake o2.4 g/day
Reduce sucrose intake
High uric acid Reduce purine intake
High oxalate Avoid high-oxalate foods
Avoid vitamin C supplements
Adequate dietary calcium intake
Low citrate Increase fruit and vegetable intake
Reduce non-dairy animal protein intake
Low volume Increase total fluid intake to maintain urine
volume 42 l/day
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variation can exist between individuals with respect to the
alimentary absorption of oxalate. For instance, up to one-
third of patients with calcium oxalate nephrolithiasis may
experience increased absorption of dietary oxalate, and in
some cases a deficiency of oxalate degradation by Oxalobacter
formigenes in the gut could be the culprit.10
Because past measurements of the oxalate content in food
may be unreliable, prospective studies of the relation between
dietary oxalate and the risk of kidney stone formation have
not been conducted. Recently, however, reliable assays for the
direct determination of the oxalate content of food, including
ion chromatography and capillary electrophoresis, have been
developed, and large-scale studies of the relation between
dietary oxalate and kidney stone formation are ongoing.
Calcium stone formers with hyperoxaluria should limit
their intake of certain nuts (including almonds, peanuts,
cashews, walnuts, and pecans), certain vegetables (including
beets and spinach), wheat bran, rice bran, and chocolate.
Sodium
High sodium intake, and a subsequent decrease in proximal
sodium reabsorption, reduces renal tubular calcium reab-
sorption. Randomized trial data confirm the powerful effect
of concomitant dietary sodium and animal protein restric-
tion on reducing urinary calcium excretion.9 Observational
studies found a positive, independent association between
sodium consumption and new kidney stone formation in
women but not men.5,6
Potassium
Dietary potassium restriction can increase urinary calcium
excretion. Hypokalemia stimulates tubular citrate reabsorp-
tion, thereby decreasing the urinary excretion of citrate, an
important inhibitor of calcium oxalate stone formation.
Potassium in food also accompanies organic anions such as
citrate that are metabolized to bicarbonate. Thus, the
consumption of potassium-containing foods such as fruits
and vegetables represents an alkali load that increases the
urinary excretion of citrate. Higher potassium intake is
inversely associated with incident kidney stones in men and
older women,5,6 but not younger women.7
Animal protein
The metabolism of sulfur-containing amino acids in animal
flesh generates sulfuric acid. As such, dietary animal protein
represents an acid load that increases urinary calcium
excretion and reduces urinary citrate excretion. Dietary
protein may also lead to an increase in calcitriol production
(possibly induced by an increase in renal mass). A positive
association between animal protein consumption and new
kidney stone formation has been shown in men but not
women.5–7
Phytate
Phytate (inositol hexaphosphate) has come under increasing
scrutiny as a dietary factor that may play a role in the
formation of calcium-containing stones. Phytate (found in
many foods high in fiber, such as cereals, legumes, and
vegetables) binds strongly to calcium and exhibits a strong
inhibitory effect on urinary crystallization of calcium salts
such as calcium oxalate and calcium phosphate. Urinary
levels of phytate in some calcium oxalate stone formers are
abnormally low, and dietary intake contributes significantly
to urinary levels of phytate.11
Observational data from younger women showed that
dietary phytate was inversely associated with incident kidney
stone formation.7 However, a recent study of men showed no
relation between dietary phytate and the risk of kidney stone
formation.8
Vitamin C
Vitamin C can be metabolized to oxalate; thus, higher
vitamin C intake could increase the risk of calcium oxalate
stone formation. A metabolic trial demonstrated that
1000 mg of supplemental vitamin C consumed twice daily
increased urinary oxalate excretion by 22%.12 A recent
observational study in men found that those who consumed
1000 mg or more per day of vitamin C had a 40% higher risk
of stone formation compared to men who consumed less
than 90 mg/day (the recommended dietary allowance).8
Because this relation was observed only after adjusting for
dietary potassium intake, we do not recommend restricting
dietary vitamin C (as foods high in vitamin C are also high in
inhibitory factors such as potassium). However, a calcium
stone former with hyperoxaluria should be instructed to
discontinue vitamin C supplements.
Magnesium
Magnesium complexes with oxalate, potentially decreasing
calcium oxalate supersaturation in the urine. Magnesium
may also reduce oxalate absorption in the gastrointestinal
tract. There have been a few randomized trials examining the
impact of magnesium supplementation on stone recurrence.
However, magnesium was given in combination with other
compounds (e.g., thiazide diuretic or potassium citrate) and
the dropout rates were high. It is uncertain whether
magnesium supplementation has an independent beneficial
effect. Higher dietary magnesium was associated with a 30%
lower risk of stone formation in men,8 but no association has
been observed in women.6,7
Carbohydrates
Carbohydrate ingestion results in increased urinary calcium
excretion, an effect that may be at least partially mediated by
insulin. A positive association between sucrose intake and
new kidney stone formation has been shown in women but
not men.5–7
Vitamin B6
Vitamin B6 is a cofactor in oxalate metabolism, and vitamin
B6 deficiency increases oxalate production and oxaluria.
Although vitamin B6 has a therapeutic role in selected
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patients with type 1 primary hyperoxaluria,13 the use
of vitamin B6 in other settings remains unclear. Observa-
tional data failed to identify vitamin B6 consumption as a
risk factor for stone formation in men.14 In women, large
doses of vitamin B6 may reduce the risk of kidney stone
formation.15
Phosphorus
Phosphorus decreases intestinal absorption of dietary
calcium. Neutral phosphate supplementation can decrease
renal calcium excretion. Human data to support the role of
dietary phosphorus as a risk factor for calcium stones are
lacking.
n-3 fatty acids
It has been proposed that dietary fatty acids modulate the
urinary excretion of calcium and oxalate, and that fish oil
supplementation lowers urinary calcium and oxalate. How-
ever, a recent prospective study showed no association
between the intake of n-3 fatty acids and the risk of kidney
stone formation.16
Calories
Higher body mass index, higher weight, larger waist
circumference, and weight gain are associated with an
increased risk of kidney stone formation, independent of
diet.17 Although there are no data currently to support
weight loss as treatment for stone disease, stone formers
should exercise and modulate their intake of calories as
needed to maintain a healthy weight.
BEVERAGES AND CALCIUM STONES
Total fluid
Nephrolithiasis is a disease of concentration. Modifying the
concentration of the lithogenic factors is the focus of stone
prevention. The concentration of calcium, for example, can
be lowered by reducing urinary calcium or by increasing
urine volume. Thus, fluid intake is a critical component of
stone prevention. Observational studies5–7 and a randomized
controlled trial18 have demonstrated that higher fluid intake
reduces the risk of stone formation. However, patients need
to be given specific advice on how much to drink to form at
least 2 l of urine per day. In addition to fluid intake, other
factors such as insensible loss and water contained in foods
influence urine volume. Rather than broadly recommending
eight glasses of water per day, the recommendation can be
tailored to the individual patient by using the information on
total volume from the 24 h urine collections. For example, if
an individual produces 1.5 l of urine per day, consuming an
additional two eight ounce (240 ml) glasses of water would
raise their output to the target of 2 l.
Some clinicians believe that a patient should have urine
that is very light in color and should wake up at least once
per night. There are no data to support the use of color as a
guide, and the desire to have constantly dilute urine needs to
be balanced against the need for sleep.
Individual beverages
Patients often want to know what they should and should not
drink. The role of specific beverages in kidney stone
formation is delineated in Table 3. Despite previous beliefs
to the contrary, alcoholic beverages, coffee, and tea do not
increase the risk of stone formation. In fact, observational
studies have found that coffee, tea, beer, and wine reduce the
risk of stone formation.19,20 Although citrus juices theoreti-
cally could reduce the risk of stone formation, there was no
association with orange juice; grapefruit juice intake was
associated with a 40% higher risk of stone formation.19,20
Grapefruit juice is known to have a number of effects on
intestinal enzymes, but the mechanism for the observed
increased risk is unknown.
Previous studies suggested an increased risk for soda
consumption. In the observational studies, unadjusted results
also suggested an increased risk. However, after controlling
for other dietary components, consumption of soda (with or
without caffeine; diet or sugared) was not associated with the
risk of stone formation.19,20
Milk intake likely reduces the risk of calcium kidney stone
formation. In published observational data, skim and whole
milk were not associated with risk.19,20 However, the
multivariate hazard ratios presented in these studies adjusted
for the intake of dietary calcium.
PREVENTION OF STONE RECURRENCE – OTHER STONE TYPES
For the less common stone types, little data exist to
support the role of specific dietary recommendations.
Therefore, the following recommendations are based on
pathophysiology.
Uric acid stones
The two driving forces for uric acid crystal formation are the
uric acid concentration and urine pH (the solubility of uric
acid increases substantially as the urine pH increases from 5.0
to 6.5). Decreasing the consumption of meat, chicken, and
seafood will decrease purine intake and uric acid production,
and also may increase urinary pH. Higher intake of fruits and
vegetables may raise the urine pH and reduce the risk of uric
acid crystal formation.
Table 3 | Beverage type and possible effects on calcium stone
formationa
Beverage type Putative risk Proposed mechanism(s)
Coffee and tea Decreased Caffeine interferes with anti-diuretic
hormone action, leading to decreased
urinary concentration
Alcohol Decreased Alcohol inhibits secretion of anti-
diuretic hormone, leading to decreased
urinary concentration
Milk Decreased Binding of dietary oxalate in gut
Grapefruit juice Increased Unknown
aOrange juice and cola are discussed in the text.
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Cystine stones
Cystine stone disease usually requires medication for
prevention. However, restricting dietary sodium may reduce
the urinary excretion of cystine. Because the solubility of
cystine increases as urinary pH rises, fruit and vegetable
consumption may be beneficial. Although there is little
evidence to support the dietary restriction of proteins high in
cystine, reducing animal protein intake may be beneficial by
increasing urine pH.
Calcium phosphate stones
Information on dietary factors related to calcium phosphate
stone formation is limited. Because patients with type 1 renal
tubular acidosis and stone disease may benefit from alkali
supplementation, generally in the form of potassium citrate,
they may also benefit from a diet high in fruits and
vegetables. It should be noted, however, that an increase in
urinary pH can increase the risk of calcium phosphate crystal
formation. Dietary maneuvers directed at decreasing urinary
calcium excretion (see Table 2) would also be expected to
decrease calcium phosphate stone recurrence.
CONCLUSION
Dietary factors play an important role in kidney stone
formation, and dietary modification can reduce the risk of
stone recurrence. Unfortunately, randomized trial data are
lacking for most dietary interventions. Given the complexity
of stone disease, clinical recommendations should be based
on studies examining actual kidney stone formation rather
than changes in urine composition. Most stone formers will
need to increase fluid intake to produce at least 2 l of urine
per day, and the calcium oxalate stone former with hyper-
calciuria should be encouraged to eat a diet with adequate
calcium and low in animal protein and sodium. Dietary
interventions, and subsequent evaluations of therapeutic
efficacy, should be based on the results of multiple 24-h
urine collections.
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